PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
3.02 - 3.02
2.85 - 3.74
400 / 3.8K (Avg.)
12.58 | 0.24
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
46.67%
Revenue growth above 1.5x IXX.DE's 15.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
48.07%
Gross profit growth above 1.5x IXX.DE's 15.74%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
1383.88%
EBIT growth above 1.5x IXX.DE's 14.24%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
1383.88%
Operating income growth above 1.5x IXX.DE's 210.40%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
202.37%
Net income growth above 1.5x IXX.DE's 3.00%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
211.76%
EPS growth of 211.76% while IXX.DE is zero. Bruce Berkowitz would see if minimal gains can accelerate over time.
211.76%
Diluted EPS growth of 211.76% while IXX.DE is zero. Bruce Berkowitz would see if minimal gains can be scaled further for a bigger lead.
-8.33%
Share reduction while IXX.DE is at 0.12%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-8.33%
Reduced diluted shares while IXX.DE is at 0.12%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Dividend reduction while IXX.DE stands at 0.00%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
64.44%
10Y revenue/share CAGR 1.25-1.5x IXX.DE's 56.57%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
64.44%
5Y revenue/share CAGR above 1.5x IXX.DE's 27.26%. David Dodd would look for consistent product or market expansions fueling outperformance.
64.44%
3Y revenue/share CAGR above 1.5x IXX.DE's 11.99%. David Dodd would confirm if there's an emerging competitive moat driving recent gains.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
133.07%
Positive 10Y CAGR while IXX.DE is negative. John Neff might see a substantial advantage in bottom-line trajectory.
133.07%
Positive 5Y CAGR while IXX.DE is negative. John Neff might view this as a strong mid-term relative advantage.
133.07%
Positive short-term CAGR while IXX.DE is negative. John Neff would see a clear advantage in near-term profit trajectory.
17.85%
Equity/share CAGR of 17.85% while IXX.DE is zero. Bruce Berkowitz might see a slight advantage that can compound significantly over 10 years.
17.85%
Below 50% of IXX.DE's 56.93%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
17.85%
3Y equity/share CAGR at 50-75% of IXX.DE's 30.63%. Martin Whitman sees a short-term lag in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
18.18%
AR growth of 18.18% while IXX.DE is zero. Bruce Berkowitz wonders if the firm’s additional AR is warranted by strong revenue or potential risk.
5.26%
Inventory growth well above IXX.DE's 9.76%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.63%
Asset growth well under 50% of IXX.DE's 11.66%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
18.30%
BV/share growth above 1.5x IXX.DE's 3.82%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
-6.61%
We’re deleveraging while IXX.DE stands at 52.03%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
22.56%
SG&A growth well above IXX.DE's 1.69%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.